News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • T-Mobile posted $18.4 billion of free cash flow, underpinning its financial flexibility.
  • The stock trades around 16x forward P/E, implying a moderate valuation.
  • Analysts have revised earnings estimates higher ahead of T-Mobile's results, lifting bullish sentiment.
  • A 45-trading-day long trade with defined entry, stop and target was proposed.
  • The trade plan lists specific catalysts and risks that would invalidate the thesis.
  • Investors view this as a short-term, valuation-and-cash-flow-driven buying opportunity.

Latest Articles

KKR Named Preferred Bidder in Talks to Acquire Portugal’s Logoplaste

KKR Named Preferred Bidder in Talks to Acquire Portugal’s Logoplaste

KKR & Co. has been identified as the preferred bidder to acquire Portuguese packaging manufacturer Logoplaste, entering exclusive negotiations with the company’s owners after rival Apax Partners withdrew from the process. Ontario Teachers’ Pension Plan Board, which holds a 60% stake in Logoplaste, has been pursuing a sale with advisers. Binding off…

Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder

Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder

Optimi Health Corp., a pharmaceutical company specializing in regulated psychedelic drug products, announced plans to begin a Health Canada-authorized Phase 3 clinical trial in 2027 evaluating MDMA-assisted therapy for PTSD. The trial will enroll up to 100 participants, focusing on veterans and frontline workers. This follows Optimi's recent Phase …

MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial

MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial

MAIA Biotechnology has dosed the first U.S. patient in the Phase 2 THIO-101 clinical trial evaluating its lead drug candidate, ateganosine, for third-line treatment of non-small cell lung cancer (NSCLC). This expansion follows FDA clearance and is funded by a $2.3 million NIH grant. Prior data shows promising survival outcomes, and the trial aims t…

BofA: European IT Services Recovery Strengthens in August

BofA: European IT Services Recovery Strengthens in August

BofA Securities' European IT Services Indicator moved back into broadly neutral territory in August, extending a recovery that began in June. Four of the indicator's six components improved, offset in part by softer EU services PMI readings and stable global IT services earnings sentiment. BofA notes a correlation between the indicator and organic …

Novo Nordisk and Anthropic Join Forces to Accelerate Drug Discovery with AI

Novo Nordisk and Anthropic Join Forces to Accelerate Drug Discovery with AI

Novo Nordisk announced on Wednesday a strategic collaboration with Anthropic to apply Anthropic’s advanced AI models to the pharmaceutical company’s drug discovery and R&D processes. The agreement will pair Anthropic’s frontier models and Claude Science with Novo Nordisk’s scientific teams to address complex research problems, enhance biological re…

Bull Case Tightens for Palladyne AI: Defense Partnerships and Short Interest Create a Tactical Long Opportunity

Bull Case Tightens for Palladyne AI: Defense Partnerships and Short Interest Create a Tactical Long Opportunity

Palladyne AI (PDYN) remains a speculative play but recent partnership announcements, successful swarm autonomy tests and heavy short interest create an asymmetric trade setup. Market cap sits near $280M while balance-sheet metrics show liquidity but ongoing cash burn. For nimble traders: enter $5.72, stop $4.70, target $9.00 over a mid-term 45 trad…

VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs

VivoSim Labs Unveils New NAMkind™ Drug Toxicity Data at EUROTOX 2026, Demonstrating Predictive Superiority in Liver and Gastrointestinal Safety Across Small Molecules and ADCs

VivoSim Labs presented new clinical benchmark data for its NAMkind™ 3D human liver and intestinal platforms at EUROTOX 2026. The data demonstrate superior predictive ability for drug toxicity across small molecules and antibody-drug conjugates (ADCs), particularly in assessing liver and gastrointestinal safety. The technology helps pharmaceutical c…

Stellantis to Unveil New Mobility Vision with Nine Concept Cars, October 12-18 at Paris Motor Show

Stellantis to Unveil New Mobility Vision with Nine Concept Cars, October 12-18 at Paris Motor Show

Stellantis announced it will showcase nine concept cars from eight of its brands along with over 60 vehicles at the Paris Motor Show in October 2026. This event underscores the company’s renewed ambition under its FaSTLAne 2030 strategic plan, featuring international premieres including electric and hybrid models from brands such as DS Automobiles,…

Vulcan Materials: Use the Bounce to Short - A Mid-Term Trade Plan

Vulcan Materials: Use the Bounce to Short - A Mid-Term Trade Plan

Vulcan Materials (VMC) has slid from its 2026 highs and now trades near $249, sitting just above its recent low of $246.2. Fundamentals are solid but cyclical exposure and weakening housing/infrastructure demand create downside risk. We favor a tactical short on a bounce to $255 with a stop at $275 and a primary target of $225 over a mid-term horiz…

Magnite Advances Agentic Vision as Major Media Owners, Buyers and Technology Players Leverage Orchestration Layer

Magnite Advances Agentic Vision as Major Media Owners, Buyers and Technology Players Leverage Orchestration Layer

Magnite, the largest independent sell-side advertising company, announced enhanced omnichannel capabilities and third-party integrations for its Magnite Orchestration platform. This orchestration layer connects agents in a shared environment, enabling AI-driven buying systems to seamlessly discover and optimize premium inventory across linear TV, s…

Globavend Expands from Digital to Live Entertainment with K-Pop Star OK TAECYEON’s Macau Fan Meeting, Targeting US$5.97 Billion Southeast Asian Market

Globavend Expands from Digital to Live Entertainment with K-Pop Star OK TAECYEON’s Macau Fan Meeting, Targeting US$5.97 Billion Southeast Asian Market

Globavend Holdings Limited (NASDAQ: GVH) announced its expansion from digital entertainment into live entertainment through its subsidiary Loomi Entertainment, organizing a major K-pop fan meeting in Macau featuring OK TAECYEON. Building on the success of a sold-out MAMAMOO concert in Hong Kong, Globavend aims to leverage synergies between digital …

Mercury Systems Announces Extension of Employment Contract with Chairman and CEO Bill Ballhaus and Reaffirms Prior Guidance

Mercury Systems Announces Extension of Employment Contract with Chairman and CEO Bill Ballhaus and Reaffirms Prior Guidance

Mercury Systems, a leader in aerospace and defense electronics, has extended the employment contract of Chairman and CEO Bill Ballhaus for three more years until August 2030. The company reaffirmed its prior financial guidance, reflecting confidence in ongoing strong operational results and improved growth prospects across its portfolio. Leadership…

NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results

NeOnc Executives Invest Approximately $629,000 in Open-Market Stock Purchases Following Positive NEO100 Phase 2a Results

NeOnc Technologies Holdings, Inc. announced that its top executives, including the CEO and Chief Medical Officer, have bought a combined total of approximately $629,000 in NeOnc shares on the open market following positive Phase 2a trial results for NEO100, a CNS cancer drug showing promising efficacy. The encouraging trial outcomes and subsequent …

TOP Ships Inc. Announces Net Income of $6.5 Million, Diluted Earnings per Share of $0.61 and Stockholders’ Equity of $76.7 Million for the Six Months Ended June 30, 2026

TOP Ships Inc. Announces Net Income of $6.5 Million, Diluted Earnings per Share of $0.61 and Stockholders’ Equity of $76.7 Million for the Six Months Ended June 30, 2026

TOP Ships Inc. announced net income of $6.5 million and EBITDA of $17.2 million for the six months ended June 30, 2026, driven by profitable operations and significant cash generation. The company is reshaping its growth with a newbuilding program of eight high-specification MR product tankers and the acquisition of three additional vessels, all un…

Teva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia Care

Teva Launches LongActingImpact.com to Advance Understanding of Earlier, Effective and Uninterrupted Schizophrenia Care

Teva Pharmaceutical Industries Ltd. has launched LongActingImpact.com, an educational online platform aimed at healthcare providers to improve understanding and discussion of long-acting injectable treatments (LAIs) for schizophrenia. The initiative seeks to overcome barriers in treatment adherence and improve long-term patient outcomes by providin…

OSS Receives Award Supporting U.S. Missile Defense Agency

OSS Receives Award Supporting U.S. Missile Defense Agency

One Stop Systems, Inc. (OSS) has received a $400,000 contract from a leading U.S. defense prime contractor to supply its latest 4UP Max PCIe platform equipped with eight NVIDIA RTX PRO 6000 Blackwell GPUs. This system will enhance advanced modeling and simulation capabilities for the U.S. Missile Defense Agency, representing a significant upgrade i…

Delixy Holdings Limited Signs Non-Binding Letter of Intent for Strategic Transaction Involving Up to 48% Interest in East Kazakhstan Sarybulak Oil Field

Delixy Holdings Limited Signs Non-Binding Letter of Intent for Strategic Transaction Involving Up to 48% Interest in East Kazakhstan Sarybulak Oil Field

Delixy Holdings Limited, a Singapore-based oil trading company listed on Nasdaq (DLXY), announced a non-binding letter of intent to acquire or merge up to a 48% interest in Tarbagatay Munay (TBM), operator of the Sarybulak Oil Field in East Kazakhstan. The strategic move aims to expand Delixy's business from oil trading into upstream oil and gas pr…